AMTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aemetis Inc (AMTX) is not a strong buy for a beginner, long-term investor at this time. While the stock has shown a significant regular market price increase recently, technical indicators suggest the stock is overbought, and financial performance has been weak with declining revenue and net income. Additionally, there are no strong proprietary trading signals or significant positive catalysts to support a buy decision.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 88.229, signaling the stock is overbought. Key resistance levels are at 1.871 and 2.022, with support at 1.382 and 1.231. The stock recently experienced a 24.68% regular market increase, but pre-market and post-market changes show slight declines.
The company reported a 61% YoY increase in net income from its biogas segment in Q4 2025, and gross margin improved by 35.42% YoY.
The company also missed its Q4 revenue expectations. Analysts estimate a negative EPS of -$0.22 for Q4.
In Q4 2025, revenue decreased to $43.31 million (-7.87% YoY), net income dropped to -$5.33 million (-67.09% YoY), and EPS fell to -$0.08 (-75% YoY). Gross margin improved to -10.4% (+35.42% YoY).
There is no recent trend in analyst ratings or price target changes provided for AMTX.
